Sebastian Other-Gee Pohl has been announced as the recipient of an EACR-Boehringer Ingelheim Postdoctoral Fellowship, funding that is awarded for a period of up to three years to support excellent postdoctoral researchers in laboratories throughout Europe.

Jane Smith, Chief Executive Officer of the EACR, congratulated Sebastian Other-Gee Pohl on his achievement, stating, “We are thrilled to have Sebastian as the first recipient of an EACR-Boehringer Ingelheim Postdoctoral Fellowship. We extend our gratitude to Boehringer Ingelheim for their support in nurturing researchers like Sebastian and fostering cutting-edge research. We look forward to hearing about Sebastian’s research in the Award Winners’ session at the EACR 2023 Congress!”

Having begun his Fellowship on 01 May 2023, Sebastian recently caught up with us to let us know how he feels about receiving this funding, “It is an honour to receive this research fellowship. The EACR and Boehringer Ingelheim have provided me with a wonderful opportunity to develop and test exciting pre-clinical models of immunotherapeutic intervention in metastatic colorectal cancer.”

About the Recipient

Sebastian is a Postdoctoral Research Fellow in the Colorectal Stem Cell Transformation Lab (Kevin Myant Lab) at the CRUK Scotland Centre, Institute of Genetics and Cancer (IGC), within the University of Edinburgh.

Originally from Newcastle, Australia, he completed his Bachelor’s in Biomedical Science from Charles Darwin University in the Northern Territory. He then moved to Perth, Western Australia to study his Master’s degree in Biomedical Science at Curtin University, specialising in molecular biotechnology at the Curtin Health and Innovation Research Institute (CHIRI). He continued at CHIRI for my PhD, which was conducted in the Stem Cell and Cancer Biology Laboratory where he was awarded a Researching Cancer Scholarship funded by the Belmont Rotary Club of WA.

Additionally, he was welcomed as a visiting researcher at the National University of Singapore’s Cancer Science Institute (CSI). His PhD explored non-canonical roles of an RNA helicase, DDX20’s regulation of Wnt signalling and cell fate through redox dependent mechanisms in breast cancer. His thesis achieved a Chancellor’s commendation.

His current research focuses on discovering and exploiting therapeutic vulnerabilities in colorectal cancer, with main interests in alternative RNA splicing, cellular plasticity, and immunotherapies. To explore his current research questions, he develops CRISPR/Cas9 edited organoid models, which are used both in vitro and in vivo, and generate genetically modified mouse models of colorectal cancer. These are used in combination with developing functional CRISPR screens for target identification.

Click here to see Sebastian Other-Gee Pohl’s institute profile page

More about EACR-Boehringer Ingelheim Postdoctoral Fellowships

The aims of this funding are to support the career development of outstanding EACR early career members, and to train the next generation of scientists engaged in innovative research in areas where Boehringer-Ingelheim has demonstrated leadership through its pipeline and research programs. Learn more here.